Showing results (71-80 of 113) with videos related to
Sort By:
Pageof 12
Gastro Hep Advances|August 12, 2024
The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis CHidenori Toyoda, Masanori Atsukawa, Haruki Uojima, et al.The American Journal of Gastroenterology|June 2, 2021
Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term EntecavirMindie H Nguyen, Masanori Atsukawa, Toru Ishikawa, et al.Journal of Gastroenterology and Hepatology|January 31, 2024
Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinomaHidenori Toyoda, Toshifumi Tada, Haruki Uojima, et al.Alimentary Pharmacology & Therapeutics|March 16, 2019
The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter studyMasanori Atsukawa, Akihito Tsubota, Hidenori Toyoda, et al.Journal of Gastroenterology and Hepatology|August 26, 2018
Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter studyMasanori Atsukawa, Akihito Tsubota, Hidenori Toyoda, et al.BMC Gastroenterology|December 21, 2021
Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective studyFumitaka Suzuki, Yoshiyuki Suzuki, Yoshiyasu Karino, et al.Journal of Medical Virology|March 6, 2026
Changes in the Liver Fibrosis of Patients Who Develop Hepatocellular Carcinoma After a Sustained Virologic Response to Hepatitis C Virus InfectionHidenori Toyoda, Akito Nozaki, Atsushi Hiraoka, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 11, 2021
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysisMakoto Chuma, Haruki Uojima, Nobuhiro Hattori, et al.Hepatology Communications|March 28, 2022
Mac-2-binding protein glycan isomer predicts all malignancies after sustained virological response in chronic hepatitis CKazuhito Kawata, Masanori Atsukawa, Kazuyoshi Ohta, et al.Clinical and Experimental Gastroenterology|October 16, 2020
Safety and Efficacy of Lenvatinib Treatment in Child-Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter AnalysisKatsuaki Ogushi, Makoto Chuma, Haruki Uojima, et al.Pageof 12